期刊
CHEMICAL BIOLOGY & DRUG DESIGN
卷 75, 期 1, 页码 40-50出版社
WILEY
DOI: 10.1111/j.1747-0285.2009.00913.x
关键词
CD36; conformational constraint; cyclic sulfamidate; Freidinger-Veber lactam; GHRP-6; GHS-R1a; lactam; lactam scanning; peptide; peptidomimetic; solid-phase synthesis
资金
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Universite de Montreal, Canadian Institutes of Health Research [CIP-79 848]
- CIHR-Team in GPCR allosteric regulation (CTiGAR)
- Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)
- The Ministre du Developpement Economique
- de l'Innovation et de l'Exportation du Quebec
- Canadian Foundation
Incorporation of amino lactams into biologically active peptides restricts conformational mobility and may enhance selectivity and increase potency. alpha- and beta-amino gamma-lactams (Agl and Bgl), in both S and R configurations, were introduced into the growth hormone secretagogue GHRP-6 using a Fmoc-compatible solid-phase protocol relying on N-alkylation with five- and six-membered cyclic sulfamidates, followed by lactam annulation under microwave heating. Using this protocol in conjunction with IRORI KanTM techniques furnished eleven new GHRP-6 analogs, and their binding affinity IC50 values on both the growth hormone secretagogue receptor 1a (GHS-R1a) and CD36 receptors are herein reported. The results indicate that selectivity towards one receptor or the other can be modulated by lactam substitution, typically at the Ala3 and the d-Phe5 positions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据